IDYA
IDEAYA Biosciences, Inc.
There isn't enough reported data to score IDYA yet.
UNH
UnitedHealth Group Incorporated
UNH's fundamentals are mixed: free cash flow grew 31%, but earnings per share fell 8.5%. At 23x earnings, it's trading right at its usual valuation. Analysts expect strong earnings growth, though they disagree widely on how much.
IDYA Fundamentals
| Metric | Status |
|---|---|
| Unavailable | |
| Weak | |
| Weak | |
| Unavailable |
IDYA's profitability and cash flow are currently weak. There isn't enough data to rate its revenue and balance sheet.
UNH Fundamentals
| Metric | Status |
|---|---|
| Stable | |
| Stable | |
| Healthy | |
| Healthy |
UNH's cash flow and balance sheet are currently healthy, and its revenue and profitability are stable.
IDYA PE Valuation
IDYA has no meaningful PE right now: it lost money over the past year.
UNH PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Forward | 18x | $405 | — |
| Cheap | 19x | $325 | -20% |
| Fair | 23x | $410 | +1.2% |
| Current | 23x | $405 | — |
| Expensive | 30x | $526 | +30% |
Historical ranges are pointers, not guarantees.
UNH's PE is in its fair range at 23x. If earnings grow as analysts expect, today's price would be 18x next year's earnings, in its cheap range.
IDYA Forward outlook
| Metric | Outlook |
|---|---|
| -- | |
| Losses growing | |
| Strong growth | |
| -- | |
| Limited | |
| Low |
Analysts expect IDYA's losses to grow, with revenue growing. However, they disagree widely on these estimates.
UNH Forward outlook
| Metric | Outlook |
|---|---|
| Strongly improving | |
| Strong growth | |
| Stable | |
| Improving | |
| Moderate | |
| Low |
Analysts expect UNH's earnings to grow and its profitability to improve, with its revenue holding steady. However, they disagree widely on these estimates.
IDYA Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Q3 2026 | -$4.46 | -$2.54 |
| Q2 2026 | -$1.91 | +$1.94 |
| Q1 2026 | -$1.57 | +$2.08 |
| Q4 2025 | -$1.28 | +$2.08 |
| Q3 2025 | -$1.92 | +$0.40 |
| Q2 2025 | -$3.85 | -$1.67 |
| Q1 2025 | -$3.65 | -$1.65 |
| Q4 2024 | -$3.36 | -$1.40 |
IDYA lost $4.46 per share over the past year, and its loss has widened in each of the last three quarters.
UNH Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Forward | $22.65 | +29% |
| Q3 2026 | $17.55 | -8.5% |
| Q2 2026 | $15.58 | -33% |
| Q1 2026 | $13.28 | -44% |
| Q4 2025 | $13.23 | -15% |
| Q3 2025 | $19.17 | +25% |
| Q2 2025 | $23.09 | +53% |
| Q1 2025 | $23.89 | +46% |
| Q4 2024 | $15.51 | -35% |
UNH has the edge over IDYA on earnings quality, reporting a profit while its opponent remains loss making.
IDYA Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $10.2M | -95% |
| Q4 2025 | $10.9M | +55% |
| Q4 2024 | $7M | +78% |
| Q4 2023 | $3.9M | -2.5% |
| Q3 2023 | $8M | -73% |
| Q2 2023 | $3.5M | -39% |
| Q1 2023 | $7.9M | -31% |
| Q4 2022 | $4M | +36% |
IDYA's revenue has slid since its 2025 peak: $10M last quarter, down 95% from the same quarter a year ago.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | -1344% | -1396 points |
| Q2 2026 | -1381% | N/A |
| Q1 2026 | -1655% | N/A |
| Q4 2025 | -870% | +1190 points |
| Q3 2025 | 52% | N/A |
| Q4 2024 | -2059% | -990 points |
| Q4 2023 | -1069% | -411 points |
| Q3 2023 | -417% | -419 points |
IDYA's operating margin was −1344% last quarter, down 1396 points from the same quarter a year ago.
UNH Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $112.7B | -0.4% |
| Q2 2026 | $112B | +0.4% |
| Q1 2026 | $111.7B | +2% |
| Q4 2025 | $113.2B | +12% |
| Q3 2025 | $113.2B | +12% |
| Q2 2025 | $111.6B | +13% |
| Q1 2025 | $109.6B | +9.8% |
| Q4 2024 | $100.8B | +6.8% |
UNH has the edge over IDYA on sales, with more consistent year-over-year improvement.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | 5.8% | +2 points |
| Q2 2026 | 7.1% | +2.5 points |
| Q1 2026 | 8.1% | -0.3 points |
| Q4 2025 | 0.3% | -7.4 points |
| Q3 2025 | 3.8% | -4.8 points |
| Q2 2025 | 4.6% | -3.4 points |
| Q1 2025 | 8.3% | +0.4 points |
| Q4 2024 | 7.7% | -0.4 points |
UNH has the edge over IDYA on profitability, with a higher operating margin.
IDYA Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | -$93.8M | -166% |
| Q2 2026 | -$89.1M | -$25.9M |
| Q1 2026 | -$76.1M | -$14.5M |
| Q4 2025 | -$90.8M | +$31.9M |
| Q3 2025 | $142.2M | +$191.9M |
| Q2 2025 | -$63.1M | -$29.3M |
| Q1 2025 | -$61.7M | -$16.5M |
| Q4 2024 | -$122.8M | -$98.2M |
IDYA has burned cash in almost every quarter: −$350M over the past year, against −$105M the year before.
UNH Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | $4.3B | -16% |
| Q2 2026 | $10.3B | +63% |
| Q1 2026 | $8.1B | +79% |
| Q4 2025 | $160M | -89% |
| Q3 2025 | $5.1B | -61% |
| Q2 2025 | $6.3B | +6.9% |
| Q1 2025 | $4.6B | +1037% |
| Q4 2024 | $1.5B | +$7.6B |
UNH has the edge over IDYA on cash generation, producing positive trailing cash flow while its opponent burns cash.
IDYA Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | +12% | +10.9M shares |
| 1 year | +15% | +13.3M shares |
| 3 years | +83% | +46.7M shares |
| 5 years | +213% | +70.1M shares |
| Available history | +408% | +82.7M shares |
IDYA has 103M diluted shares, up 15% from a year ago.
UNH Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | -0.4% | -4M shares |
| 1 year | -0.7% | -6M shares |
| 3 years | -3.6% | -34M shares |
| 5 years | -5.5% | -53M shares |
| Available history | -6.6% | -64M shares |
UNH has the edge over IDYA on shareholder dilution, with a more favorable share count trend.
| Quarter | Spent |
|---|---|
| Q3 2026 | $3.4B |
| Q2 2026 | $1.6B |
| Q1 2026 | — |
| Q4 2025 | — |
| Q3 2025 | — |
| Q2 2025 | $2.5B |
| Q1 2025 | $3B |
| Q4 2024 | $5B |
UNH spent $5B buying back its own shares over the past year, down 52% from the year before.
IDYA Net Leverage
IDYA's operating earnings (EBITDA) were negative over the past year, so its debt can't be measured against them.
UNH Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q3 2026 | 1.7x | Healthy |
| Q2 2026 | 1.7x | Healthy |
| Q1 2026 | 2.2x | Moderate |
| Q4 2025 | 2.3x | Moderate |
| Q3 2025 | 1.7x | Healthy |
| Q2 2025 | 1.5x | Healthy |
| Q1 2025 | 1.3x | Healthy |
| Q4 2024 | 1.4x | Healthy |
UNH's net debt is about 1.7 years of its operating earnings (EBITDA), about the same as a year ago.
IDYA Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 42.2 | Neutral |
| Stochastic | 5.8 | Oversold |
IDYA's weekly RSI is 42 (neutral) and its Stochastic is 6 (oversold).
UNH Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 56.4 | Neutral |
| Stochastic | 60.0 | Neutral |
UNH's weekly RSI is 56 (neutral) and its Stochastic is 60 (neutral).
IDYA PE vs Healthcare Sector
IDYA has no meaningful PE right now: it lost money over the past year.
UNH PE vs Healthcare Sector
| Metric | UNH | Sector median | Relative |
|---|---|---|---|
| PE | 23x | 26x | 11% below |
| PE % | 47 | 29 | 18 pts above |
UNH is trading at 23x earnings, a 11% discount to the Healthcare sector's median of 26x.
IDYA Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $34.1 | 7.5% below |
| 20 week MA | $36.2 | 13% below |
| 50 week MA | $33.8 | 6.7% below |
| 100 week MA | $28.6 | 10% above |
| 200 week MA | $29.5 | 6.6% above |
IDYA has slipped below its 8-, 20- and 50-week averages, though it's still 6.6% above its 200-week average.
UNH Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $394.2 | 2.8% above |
| 20 week MA | $400.5 | 1.2% above |
| 50 week MA | $361.2 | 12% above |
| 100 week MA | $376.0 | 7.8% above |
| 200 week MA | $446.6 | 9.3% below |
UNH has the edge over IDYA on trend strength, trading above more of its moving averages.
IDYA Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $8.50 | $12.9 | +52% |
| 2021 | $12.9 | $23.4 | +81% |
| 2022 | $23.4 | $17.0 | -27% |
| 2023 | $17.0 | $35.6 | +109% |
| 2024 | $35.6 | $25.2 | -29% |
| 2025 | $25.2 | $35.2 | +40% |
| 2026 YTD | $35.2 | $31.5 | -11% |
IDYA has finished higher in four of the last six years, three of them by more than 50%. It's down 11% so far in 2026.
UNH Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $296.0 | $340.8 | +15% |
| 2021 | $340.8 | $495.4 | +45% |
| 2022 | $495.4 | $531.3 | +7.3% |
| 2023 | $531.3 | $526.5 | -0.9% |
| 2024 | $526.5 | $510.0 | -3.1% |
| 2025 | $510.0 | $331.8 | -35% |
| 2026 YTD | $331.8 | $405.1 | +22% |
UNH has the edge over IDYA on returns for 2026, with the stronger performance.